ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ARDX Ardelyx Inc

6.555
0.155 (2.42%)
Last Updated: 12:42:09
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,678,503
Bid Price 6.55
Ask Price 6.56
News (1)
Day High 6.735

Low
3.16

52 Week Range

High
10.13

Day Low 6.41
Company Name Stock Ticker Symbol Market Type
Ardelyx Inc ARDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.155 2.42% 6.555 12:42:09
Open Price Low Price High Price Close Price Prev Close
6.45 6.41 6.735 6.40
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,305 1,678,503 $ 6.59 $ 11,063,670 - 3.16 - 10.13
Last Trade Time Type Quantity Stock Price Currency
12:42:34 53 $ 6.555 USD

Ardelyx (ARDX) Options Flow Summary

Overall Flow

Bullish

Net Premium

59k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Ardelyx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.51B 232.69M - 124.46M -66.07M -0.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ardelyx News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARDX Message Board. Create One! See More Posts on ARDX Message Board See More Message Board Posts

Historical ARDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.456.7456.23986.405,260,8380.1051.63%
1 Month7.237.876.23986.835,097,163-0.675-9.34%
3 Months9.1210.136.23988.065,580,810-2.57-28.13%
6 Months3.9510.133.437.255,791,3882.6165.95%
1 Year4.5110.133.165.535,891,5022.0545.34%
3 Years7.2510.130.49023.006,818,986-0.695-9.59%
5 Years3.3910.43430.49023.294,394,4713.1793.36%

Ardelyx Description

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Your Recent History

Delayed Upgrade Clock